Akso Health Group
AHG
5 hedge funds and large institutions have $128K invested in Akso Health Group in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0.1% less ownership
Funds ownership: 1.61% → 1.51% (-0.1%)
12% less capital invested
Capital invested by funds: $145K → $128K (-$16.8K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$1.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$9.75K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.16K |
AHG Hedge Fund Activity: Q1 2023 in Review
5 of the 6,285 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q1 2023, worth a combined $128K — down 12% from $145K a quarter earlier.
Fund positioning in AHG was balanced in Q1 2023: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Two Sigma Securities, adding an estimated $1.93K. The largest seller was Renaissance Technologies, cutting an estimated $9.75K.
- 5 institutional investors held Akso Health Group (AHG) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $128K of Akso Health Group stock for Q1 2023, down 12% quarter-over-quarter.
- 0 funds opened new Akso Health Group positions in Q1 2023 and 0 closed out.
- The largest Akso Health Group buyer in Q1 2023 was Two Sigma Securities, an estimated $1.93K added.
- The largest Akso Health Group seller in Q1 2023 was Renaissance Technologies, an estimated $9.75K sold.
Based on aggregated 13F filings for Q1 2023.